Cytotoxic activity and molecular targets of atractylodin in cholangiocarcinoma cells
AOD-9604 targets beta-3 adrenergic receptors in adipose tissue to stimulate lipolysis directly, without affecting appetite, blood glucose, or the central nervous system
IV doses of 25-400 mcg/kg for safety studies Important: These are experimental doses used in animal studies and cannot be extrapolated to other species due to significant differences in metabolism, pharmacokinetics, receptor expression, peptide degradation rates, and tissue distribution patterns
Some studies suggest its hair-growth performance is comparable to 5 % minoxidil, with fewer side effects
If you add the same 2ml of bacteriostatic water, you get a concentration of 5mg/ml instead of 2.5mg/ml
Regulators reflect this: most of these compounds are classified "for research use only" in the US and EU, and the FDA has issued warning letters to companies marketing unapproved peptide products